A Phase 2, Randomized, Double-Blind, Multicenter Trial to Evaluate the Safety and Efficacy of Three Dosing Regimens of Isavuconazole Compared With Fluconazole in Patients With Uncomplicated Esophageal Candidiasis
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.04586-14
Full Text
Open PDFAbstract
Available in full text
Date
January 5, 2015
Authors
Publisher
American Society for Microbiology